IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-018-08150-5.html
   My bibliography  Save this article

Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators

Author

Listed:
  • Daniel Aird

    (H3 Biomedicine, Inc.)

  • Teng Teng

    (H3 Biomedicine, Inc.)

  • Chia-Ling Huang

    (H3 Biomedicine, Inc.)

  • Ermira Pazolli

    (H3 Biomedicine, Inc.)

  • Deepti Banka

    (H3 Biomedicine, Inc.)

  • Kahlin Cheung-Ong

    (H3 Biomedicine, Inc.)

  • Cheryl Eifert

    (H3 Biomedicine, Inc.)

  • Craig Furman

    (H3 Biomedicine, Inc.)

  • Zhenhua Jeremy Wu

    (H3 Biomedicine, Inc.)

  • Michael Seiler

    (H3 Biomedicine, Inc.)

  • Silvia Buonamici

    (H3 Biomedicine, Inc.)

  • Peter Fekkes

    (H3 Biomedicine, Inc.)

  • Craig Karr

    (H3 Biomedicine, Inc.)

  • James Palacino

    (H3 Biomedicine, Inc.)

  • Eunice Park

    (H3 Biomedicine, Inc.)

  • Peter G. Smith

    (H3 Biomedicine, Inc.)

  • Lihua Yu

    (H3 Biomedicine, Inc.)

  • Yoshiharu Mizui

    (H3 Biomedicine, Inc.)

  • Markus Warmuth

    (H3 Biomedicine, Inc.)

  • Agustin Chicas

    (H3 Biomedicine, Inc.)

  • Laura Corson

    (H3 Biomedicine, Inc.)

  • Ping Zhu

    (H3 Biomedicine, Inc.)

Abstract

Dysregulation of RNA splicing by spliceosome mutations or in cancer genes is increasingly recognized as a hallmark of cancer. Small molecule splicing modulators have been introduced into clinical trials to treat solid tumors or leukemia bearing recurrent spliceosome mutations. Nevertheless, further investigation of the molecular mechanisms that may enlighten therapeutic strategies for splicing modulators is highly desired. Here, using unbiased functional approaches, we report that the sensitivity to splicing modulation of the anti-apoptotic BCL2 family genes is a key mechanism underlying preferential cytotoxicity induced by the SF3b-targeting splicing modulator E7107. While BCL2A1, BCL2L2 and MCL1 are prone to splicing perturbation, BCL2L1 exhibits resistance to E7107-induced splicing modulation. Consequently, E7107 selectively induces apoptosis in BCL2A1-dependent melanoma cells and MCL1-dependent NSCLC cells. Furthermore, combination of BCLxL (BCL2L1-encoded) inhibitors and E7107 remarkably enhances cytotoxicity in cancer cells. These findings inform mechanism-based approaches to the future clinical development of splicing modulators in cancer treatment.

Suggested Citation

  • Daniel Aird & Teng Teng & Chia-Ling Huang & Ermira Pazolli & Deepti Banka & Kahlin Cheung-Ong & Cheryl Eifert & Craig Furman & Zhenhua Jeremy Wu & Michael Seiler & Silvia Buonamici & Peter Fekkes & Cr, 2019. "Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators," Nature Communications, Nature, vol. 10(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-08150-5
    DOI: 10.1038/s41467-018-08150-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-08150-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-018-08150-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-08150-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.